関連する実験動画
Updated: Sep 9, 2025

07:14
Acupuncture in a Rat Model of Asthma
Published on: August 25, 2020
6.1K
レウコキニンVIIIアセテートは,ADCK5誘発の細胞老化を標的として,喘息の重症度を軽減する
Ling Feng1, Yuan Zhong2, Li Li2
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, China.
International immunopharmacology
|August 30, 2025
まとめ
この研究では,ADCK5が重症性喘息の細胞衰老に関連した重要な遺伝子であると特定しました. ADCK5を阻害し,老化を抑制することで,重度の喘息を治療する可能性がある.
科学分野:
- 肺科
- 遺伝学
- 細胞生物学
背景:
- 重度の喘息は,治療抵抗性および不良の予後のために重大な臨床的課題を提示します.
- 新規の治療目標の特定は 重度の喘息の管理を改善するために不可欠です
研究 の 目的:
- 重度の喘息において 異なった発現遺伝子 (DEGs) を特定する.
- 重度の喘息の潜在的治療目標と介入を探る
- 重度の喘息の病原性における細胞老化の役割を調査する.
主な方法:
- 重度の喘息と軽度の喘息の間のDEGのバイオ情報分析
- 細胞の老化のレベルを評価する in vitro 実験
- ハイ・スループット・コンパウンド・スクリーニング, 分子ドッキング, 実験的検証.
主要な成果:
- DEGは細胞老化に関連した長寿調節経路に濃縮された.
- 重度の喘息は 細胞の老化を高めました
- ADCK5は,重度の喘息において,高度に発現する老化関連マーカーとして,予測的価値を持つと特定された.
- レオクイニンVIIIアセテート (レオクイニン8) はADCK5の発現を阻害し,細胞老化を減少させた.
結論:
- ADCK5は重度の喘息における呼吸道老化の重要な遺伝子です.
- レウコキニン8は,ADCK5を標的とし,呼吸道老化を緩和することで,重度の喘息の治療の可能性を示しています.
関連する概念動画
Antiasthma Drugs: Leukotriene Modifiers
461
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
461
Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
Antiasthma Drugs: β2-Adrenoceptor Agonists
377
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
377
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K

